New 2018 guidelines from the National Comprehensive Cancer Network (NCCN) on molecular testing in CRC recommend that MMR/MSI testing or analysis for deficient MMR protein expression be done in all patients with newly diagnosed CRC [15]. Here, MRC1 is linked to colorectal carcinoma.